Podoplanin (D2-40) Is a Novel Marker for Follicular Dendritic Cell Tumors
Open Access
- 1 November 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 128 (5) , 776-782
Abstract
Podoplanin, recognized by monoclonal antibody D2-40, may be a useful marker for follicular dendritic cell (FDC) tumors. Paraffin sections of 125 dendKeywords
This publication has 29 references indexed in Scilit:
- Splenic Marginal-zone Lymphoma: One or More Entities? A Histologic, Immunohistochemical, and Molecular Study of 42 CasesAmerican Journal of Surgical Pathology, 2007
- Podoplanin: A Novel Diagnostic Immunohistochemical MarkerAdvances in Anatomic Pathology, 2006
- Up-Regulation of the Lymphatic Marker Podoplanin, a Mucin-Type Transmembrane Glycoprotein, in Human Squamous Cell Carcinomas and Germ Cell TumorsThe American Journal of Pathology, 2005
- Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumorsOncogene, 2004
- Clusterin Expression Distinguishes Follicular Dendritic Cell Tumors From Other Dendritic Cell NeoplasmsAmerican Journal of Surgical Pathology, 2004
- Molecular Identification of Aggrus/T1α as a Platelet Aggregation-inducing Factor Expressed in Colorectal TumorsJournal of Biological Chemistry, 2003
- T1α/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedemaThe EMBO Journal, 2003
- Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumoursBritish Journal of Cancer, 1999
- Angiosarcomas Express Mixed Endothelial Phenotypes of Blood and Lymphatic CapillariesThe American Journal of Pathology, 1999
- Follicular dendritic cell sarcomaCancer, 1997